ERBB2 and breast cancer: HER2− breast cancer samples had significantly higher ACBD3 protein expression than HER2 1+ breast cancer samples (2.038, n = 49, versus 1.055, n = 4, respective mean averages, p = 0.0107) (Figure 8d).